4631 studies found for:    genital diseases AND (woman OR women OR female)
Show Display Options
RSS Create an RSS feed from your search for:
genital diseases AND (woman OR women OR female)
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)
Conditions: Papillomavirus Infections;   Genital Diseases, Female
Interventions: Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 20/40/40/20;   Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 40/40/40/40;   Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 80/80/40/80;   Biological: Placebo (mcg) (Aluminum Adjuvant)225;   Biological: Placebo (mcg) (Aluminum Adjuvant) 450
2 Unknown  LANDA Embryo Freezing Technique.
Conditions: Primary Infertility;   Secondary Infertility;   Genital Diseases, Male;   Genital Diseases, Female
Intervention:
3 Active, not recruiting Activity, Tolerability, Safety of Temsirolimus in Women With Ovarian Cancer Who Progressed During Previous Platinum Chemotherapy or Within 6 Months After Therapy or Advanced Endometrial Carcinoma
Conditions: Genital Diseases, Female;   Ovarian Diseases;   Ovarian Neoplasms;   Endometrial Neoplasms
Intervention: Drug: Temsirolimus
4 Completed Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract
Conditions: Women's Health;   HIV Infection;   Genital Diseases, Female
Intervention:
5 Completed Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer
Conditions: Female Genital Diseases;   Ovarian Cancer;   Cervical Cancer;   Endometrial Cancer;   Vulval Cancer
Intervention:
6 Not yet recruiting Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy
Condition: Genital Diseases, Female
Interventions: Device: Guardix-FL;   Device: Interceed
7 Completed Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients
Conditions: Genital Diseases, Female;   Ovarian Neoplasms;   Urogenital Neoplasms
Intervention:
8 Completed A Study of Trabectedin in Patients With Advanced Ovarian Cancer
Conditions: Ovarian Neoplasms;   Endocrine Gland Neoplasms;   Neoplasms by Site;   Neoplasms;   Ovarian Diseases;   Adnexal Diseases;   Genital Diseases, Female
Interventions: Drug: Trabectedin;   Drug: Dexamethasone
9 Active, not recruiting Evaluation of Optimal Initial Treatment Duration of Bevacizumab in Combination With Standard Chemotherapy in Patients With Ovarian Cancer
Conditions: Genital Diseases, Female;   Ovarian Diseases;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms
Interventions: Biological: Bevacizumab;   Drug: Paclitaxel;   Drug: Carboplatin;   Other: specialized pathology review (Germany only)
10 Recruiting Effect of Salpingectomy During Conservative Hysterectomy
Conditions: Genital Diseases, Female;   Hysterotomy; Affecting Fetus;   Leiomyomata Uteri;   Adenomyosis, Endometriosis;   Dysfunctional Uterine Bleeding;   Cervical Dysplasia;   Uterine Prolapse
Interventions: Procedure: conservative hysterectomy I;   Procedure: Conservative hysterectomy II
11 Recruiting Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy
Conditions: Hysterectomy;   Genital Diseases, Female;   Pain
Interventions: Behavioral: Follow-up strategy;   Behavioral: No contact after discharge
12 Active, not recruiting Novel Topical Therapies for the Treatment of Genital Pain
Condition: Female Genital Diseases
Interventions: Drug: Amitriptyline;   Drug: Baclofen;   Drug: Ketoprofen;   Drug: Ketamine;   Drug: Loperamide;   Drug: Gabapentin;   Drug: placebo
13 Active, not recruiting GARDASIL™ Vaccine Impact in Population Study (V501-033)
Condition: Human Papillomavirus Infections
Intervention:
14 Active, not recruiting Prevention of HPV in 20 to 45 Year Old Chinese Women (V501-041)
Condition: HPV Infections
Interventions: Biological: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine;   Biological: Comparator: placebo (unspecified)
15 Completed Eeva™ Continued Access Study: Assessing the Usability of Eeva in a Clinical Setting
Condition: Infertility
Intervention:
16 Not yet recruiting ADXS11-001 High Dose HPV+ Cervical Cancer
Conditions: Effects of Immunotherapy;   Metastatic/Recurrent Cervical Cancer;   Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Intervention: Biological: ADXS11-001
17 Enrolling by invitation Prevention of Female Genital Schistosomiasis (FGS) in Rural High-endemic South Africa
Condition: Uro-genital Schistosomiasis
Intervention: Other: praziquantel
18 Active, not recruiting Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
Conditions: Ovarian Cancer;   Endometrial Cancer;   Uterine Cervical Cancer
Interventions: Drug: Filgrastim;   Drug: Paclitaxel;   Drug: Carboplatin
19 Active, not recruiting A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Conditions: Solid Tumors and Advanced Endometrial Cancer;   Endometrial Cancer;   Second-line Treatment;   VEGF
Intervention: Drug: TKI258
20 Unknown  Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm
Conditions: Male Infertility;   Testicular Diseases;   Urologic and Male Genital Diseases;   Lead Poisoning
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years